Additional Metadata
Persistent URL dx.doi.org/10.1007/s12020-018-1751-9, hdl.handle.net/1765/110486
Journal Endocrine : International Journal of Basic and Clinical Endocrinology
Citation
Bengtsson, D. (D.), Schrøder, H.D. (H. D.), Berinder, K, Maiter, D, Hoÿbye, C, Ragnarsson, O, … Burman, P. (2018). Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide. Endocrine : International Journal of Basic and Clinical Endocrinology. doi:10.1007/s12020-018-1751-9